Epidemiological Analysis of Fungal Infection Disease in Pediatric Population: Focus on Hospitalization from 2007 to 2022 in Veneto Region in Italy
Abstract
:1. Background
2. Methods
2.1. Setting and Data Source
2.2. Population and Acute Admissions for Fungal Infection
2.3. Hospitalization Rate and Length of Stay
2.4. Estimated Costs
2.5. Statistical Analysis
3. Results
3.1. Hospitalization for FI
3.2. DRG Analysis
3.3. Estimated Cost
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Zaoutis, T.E.; Argon, J.; Chu, J.; Berlin, J.A.; Walsh, T.J.; Feudtner, C. The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis. Clin. Infect. Dis. 2005, 41, 1232–1239. [Google Scholar] [CrossRef] [PubMed]
- Erjavec, Z.; Kluin-Nelemans, H.; Verweij, P.E. Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clin. Microbiol. Infect. 2009, 15, 625–633. [Google Scholar] [CrossRef] [PubMed]
- Nosari, A.; Caira, M.; Pioltelli, M.; Fanci, R.; Bonini, A.; Cattaneo, C.; Castagnola, C.; Capalbo, S.; De Fabritiis, P.; Mettivier, V.; et al. Hema e-Chart Registry of invasive fungal infections in haematological patients: Improved outcome in recent years in mould infections. Clin. Microbiol. Infect. 2013, 19, 757–762. [Google Scholar] [CrossRef] [PubMed]
- Suleyman, G.; Alangaden, G.J. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention. Infect. Dis. Clin. N. Am. 2021, 35, 1027–1053. [Google Scholar] [CrossRef]
- Tragiannidis, A.; Fegeler, W.; Rellensmann, G.; Debus, V.; Müller, V.; Hoernig-Franz, I.; Siam, K.; Pana, Z.-D.; Jürgens, H.; Groll, A. Candidaemia in a European Paediatric University Hospital: A 10-year observational study. Clin. Microbiol. Infect. 2012, 18, E27–E30. [Google Scholar] [CrossRef]
- Lehrnbecher, T.; Schöning, S.; Poyer, F.; Georg, J.; Becker, A.; Gordon, K.; Attarbaschi, A.; Groll, A.H. Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study. Front. Microbiol. 2019, 10, 681. [Google Scholar] [CrossRef]
- Registries, C.o.Z.a.F.; Pana, Z.D.; Seidel, D.; Skiada, A.; Groll, A.H.; Petrikkos, G.; Cornely, O.A.; Roilides, E. Invasive mucormycosis in children: An epidemiologic study in European and non-European countries based on two registries. BMC Infect. Dis. 2016, 16, 1–9. [Google Scholar] [CrossRef]
- Vasileiou, E.; Paisiou, A.; Tsipou, C.; Pourtsidis, A.; Galani, V.; Katzilakis, N.; Antoniadi, K.; Papakonstantinou, E.; Ioannidou, E.; Stiakaki, E.; et al. Candidemia in Children with Malignancies: Report from the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology. J. Fungi 2020, 6, 276. [Google Scholar] [CrossRef]
- Warris, A.; Lehrnbecher, T.; Roilides, E.; Castagnola, E.; Bruggemann, R.J.M.; Groll, A.H. ESCMID-ECMM guideline: Diagnosis and management of invasive aspergillosis in neonates and children. Clin. Microbiol. Infect. 2019, 25, 1096–1113. [Google Scholar] [CrossRef]
- Bonifaz, A.; Rojas, R.; Tirado-Sánchez, A.; Chávez-López, D.; Mena, C.; Calderón, L.; María, P.-O.R. Superficial Mycoses Associated with Diaper Dermatitis. Mycopathologia 2016, 181, 671–679. [Google Scholar] [CrossRef]
- Ray, A.; Singh, B.S.; Kar, B.R. Clinicomycological Profile of Pediatric Dermatophytoses. Indian Dermatol. Online J. 2022, 13, 361–365. [Google Scholar] [CrossRef]
- Pana, Z.D.; Roilides, E.; Warris, A.; Groll, A.H.; Zaoutis, T. Epidemiology of Invasive Fungal Disease in Children. J. Pediatr. Infect. Dis. Soc. 2017, 6, S3–S11. [Google Scholar] [CrossRef] [PubMed]
- Kullberg, B.J.; Arendrup, M.C. Invasive Candidiasis. N. Engl. J. Med. 2015, 373, 1445–1456. [Google Scholar] [CrossRef] [PubMed]
- Demographic Statistics Veneto Region (Population Density, Population, Median Age, Households, Foreigners). Available online: https://ugeo.urbistat.com/AdminStat/it/it/demografia/dati-sintesi/veneto/5/2 (accessed on 18 June 2024).
- Ferre, F.; de Belvis, A.G.; Valerio, L.; Longhi, S.; Lazzari, A.; Fattore, G.; Ricciardi, W.; Maresso, A. Italy: Health system review. Health Syst. Transit. 2014, 16, 1–168. [Google Scholar] [PubMed]
- Regione del Veneto. Decreto no. 118, “Aggiornamento Della Disciplina del Flusso Informativo ‘Scheda di Dimissione Ospedaliera’ e dei Tracciati Record”. Available online: https://salute.regione.veneto.it/c/document_library/get_file?p_l_id=8278039&folderId=1026448&name=DLFE-31626.pdf (accessed on 18 June 2024).
- Istat (Istituto Nazionale di Statistica). Available online: https://salute.regione.veneto.it/c/document_library/get_file?p_l_id=8278039&folderId=1026448&name=DLFE-31626.pdf (accessed on 18 June 2024).
- Regione del Veneto. Allegato A. Tariffe DRG. Available online: https://salute.regione.veneto.it/c/document_library/get_file?p_l_id=8278039&folderId=1026448&name=DLFE-32075.xls (accessed on 18 June 2024).
- Kim, H.J.; Fay, M.P.; Feuer, E.J.; Midthune, D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 2000, 19, 335–351, Erratum in: Stat. Med. 2001, 20, 655. [Google Scholar] [CrossRef]
- Kaur, H.; Chakrabarti, A. Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries. J. Fungi 2017, 3, 41. [Google Scholar] [CrossRef]
- Cook, A.; Ferreras-Antolin, L.; Adhisivam, B.; Ballot, D.A.; Berkley, J.; Bernaschi, P.; Carvalheiro, C.G.; Chaikittisuk, N.; Chen, Y.; Chibabhai, V.; et al. Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study. Med. Mycol. 2023, 61. [Google Scholar] [CrossRef]
- Zilberberg, M.D.; Shorr, A.F.; Kollef, M.H. Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005. Infect. Control. Hosp. Epidemiol. 2008, 29, 978–980. [Google Scholar] [CrossRef]
- Marchetti, O.; Bille, J.; Fluckiger, U.; Eggimann, P.; Ruef, C.; Garbino, J.; Calandra, T.; Glauser, M.; Tauber, M.G.; Pittet, D.; et al. Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000. Clin. Infect. Dis. 2004, 38, 311–320. [Google Scholar] [CrossRef]
- Vallabhaneni, S.; Benedict, K.; Derado, G.; Mody, R.K. Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000–2013. Open Forum Infect. Dis. 2017, 4, ofw268. [Google Scholar] [CrossRef]
- Zaoutis, T.E.; Heydon, K.; Chu, J.H.; Walsh, T.J.; Steinbach, W.J. Epidemiology, Outcomes, and Costs of Invasive Aspergillosis in Immunocompromised Children in the United States, 2000. Pediatrics 2006, 117, e711–e716. [Google Scholar] [CrossRef]
- Muthu, V.; Agarwal, R.; Rudramurthy, S.M.; Thangaraju, D.; Shevkani, M.R.; Patel, A.K.; Shastri, P.S.; Tayade, A.; Bhandari, S.; Gella, V.; et al. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM). Mycoses 2024, 67, e13745. [Google Scholar] [CrossRef] [PubMed]
- Alhumaid, S.; Alabdulqader, M.; Al Dossary, N.; Al Alawi, Z.; Alnaim, A.A.; Al Mutared, K.M.; Al Noaim, K.; Al Ghamdi, M.A.; Albahrani, S.J.; Alahmari, A.A.; et al. Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis. Trop. Med. Infect. Dis. 2022, 7, 380. [Google Scholar] [CrossRef] [PubMed]
- Osman, H.; Shaik, A.N.; Nguyen, P.L.; Cantor, Z.; Kaafarani, M.; Soubani, A.O. The Clinical Significance of Aspergillus Detected in Lower-Respiratory-Tract Samples of Critically Ill COVID-19-Positive Patients. Adv. Respir. Med. 2023, 91, 337–349. [Google Scholar] [CrossRef] [PubMed]
- Kanamori, H.; Rutala, W.A.; Sickbert-Bennett, E.E.; Weber, D.J. Review of Fungal Outbreaks and Infection Prevention in Healthcare Settings During Construction and Renovation. Clin. Infect. Dis. 2015, 61, 433–444. [Google Scholar] [CrossRef]
- World Medical Association. WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. Available online: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (accessed on 5 December 2022).
Diagnosis (N; %) | <1 Year | 1–4 Years | 5–9 Years | 10–14 Years | 15–18 Years | Total |
---|---|---|---|---|---|---|
Aspergillosis | 4 (0.5) | 26 (10) | 42 (27) | 46 (29) | 34 (28) | 152 (10.5) |
Candidiasis | 439 (60) | 151 (58) | 38 (24) | 47 (30) | 50 (40.98) | 725 (50.5) |
Diaper Candida infection | 58 (8) | 15 (6) | 1 (0.5) | 0 (0) | 0 (0) | 74 (5) |
Dermatomycosis | 23 (3) | 15 (6) | 15 (9.5) | 5 (3) | 3 (2.5) | 61 (4.5) |
Neonatal Candida infection | 175 (24) | / | / | / | / | 175 (12) |
Mycosis from facultative mycosis | 1 (1) | 4 (1.5) | 0 | 2 (1) | 4 (3) | 11 (1) |
Mycotic otitis | 0 | 2 (1) | 2 (1.5) | (1.26) | (0) | 6 (0.5) |
Pneumonia due to systemic mycosis | 6 (1) | 18 (9) | 14 (9) | 10 (6) | 8 (6.5) | 56 (4) |
Pneumonia due to Aspergillus | 2 (0.3) | 11 (4) | 19 (12) | 20 (12.5) | 5 (4) | 57 (4) |
Zygomicosis infection | 0 | 0 | 5 (3) | 1 (0.5) | 1 (1) | 7 (0.5) |
Other mycoses | 24 (3.3) | 20 (7.5) | 22 (14) | 26 (16) | 17 (14) | 109 (7.6) |
Total | 732 | 26 (100) | 158 (100) | 159 (100) | 122 (100) | 1433 (100) |
Variable | Class | n | % | Annual Hospitalization Rate per 100,000 | Days of Hospitalization (Mean; Min-Max) | Deaths (n) | CFR % | p-Value Hosp. Rate | p-Value Days of Hosp. | p-Value CFR | p-Value Costs |
---|---|---|---|---|---|---|---|---|---|---|---|
Total | Total | 1433 | 1000 | 10,839 | 14.7 (0–368) | 30 | 2094 | ||||
Age class | <1 | 732 | 51.1 | 110,552 | 10.1 (0–320) | 6 | 0.820 | <0.0001 | <0.0001 | 0.00165 | <0.0001 |
1–4 | 262 | 18.3 | 8477 | 14.5 (0–215) | 6 | 2290 | |||||
5–9 | 158 | 11.0 | 4648 | 20.1 (0–204) | 7 | 4430 | |||||
10–14 | 159 | 11.1 | 4165 | 27.8 (0–368) | 7 | 4403 | |||||
15–18 | 122 | 8.5 | 4580 | 19.1 (0–154) | 4 | 3279 | |||||
Sex | F | 657 | 45.8 | 9536 | 14.7 (0–220) | 16 | 2435 | 0.0060 | 0.3679 | 0.417 | 0.5989 |
M | 776 | 54.2 | 11.053 | 14.8 (0–368) | 14 | 1804 | |||||
Year of hospitalization | 2007 | 64 | 4.5 | 7662 | 8.1 (1–50) | 2 | 3.125 | <0.0001 | 0.06545 | 0.6132 | 0.2277 |
2008 | 109 | 7.6 | 12.832 | 11.6 (1–100) | 2 | 1835 | |||||
2009 | 96 | 6.7 | 11.112 | 11.8 (1–119) | 3 | 3125 | |||||
2010 | 100 | 7.0 | 1489 | 12.7 (0–330) | 0 | 0000 | |||||
2011 | 112 | 7.8 | 12.810 | 15.8 (0–124) | 1 | 0.893 | |||||
2012 | 119 | 8.3 | 13.600 | 18.5 (0–302) | 4 | 3361 | |||||
2013 | 116 | 8.1 | 13.224 | 17.2 (0–220) | 4 | 3.448 | |||||
2014 | 99 | 6.9 | 11,319 | 14.9 (0–334) | 2 | 2020 | |||||
2015 | 70 | 4.9 | 8049 | 14.9 (0–111) | 1 | 1429 | |||||
2016 | 91 | 6.4 | 10,567 | 18.2 (0–368) | 2 | 2198 | |||||
2017 | 98 | 6.8 | 11,513 | 10.1 (0–48) | 0 | 0000 | |||||
2018 | 78 | 5.4 | 9270 | 10.7 (0–80) | 1 | 1282 | |||||
2019 | 80 | 5.6 | 9612 | 16.6 (0–139) | 1 | 1250 | |||||
2020 | 78 | 5.4 | 9519 | 15.4 (0–154) | 2 | 2564 | |||||
2021 | 68 | 4.7 | 8396 | 20.2 (0–214) | 2 | 2941 | |||||
2022 | 55 | 3.8 | 6878 | 19.6 (1.5–204) | 3 | 5455 | |||||
Hospitalization during COVID-19 emergency | 201 | 14.0 | 8396 | 18.2 (0–214) | 7 | 3.483 | <0.0001 | 0.0021 | 0.1765 | 0.3109 | |
Prematurity | 141 | 9.8 | 242,424 | 16.6 (0–92) | 1 | 0.709 | <0.0001 | <0.0001 | 0.3534 | 0.6029 | |
Solid organ transplantation | 46 | 3.2 | 1,403,509 | 49.8 (0–344) | 12 | 26.087 | <0.0001 | <0.0001 | <0.0001 | 0.003123 | |
Immunocompromised, onco-hematological | 270 | 18.8 | 596.491 | 26.1 (0–368) | 16 | 5.926 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Cystic fibrosis | 9 | 0.6 | 26.315 | 38.6 (8–119) | 0 | 0.000 | 0.0137 | 0.0020 | 0.9999 | 0.4003 | |
N° of comorbidities | 0 | 1005 | 70.1 | 7621 | 10.5 (0–330) | 10 | 0.995 | <0.0001 | <0.0001 | <0.0001 | |
1 | 392 | 27.4 | 2768 | 23.4 (0–368) | 12 | 3061 | |||||
>1 | 36 | 2.5 | 0.250 | 39.7 (0–344) | 8 | 22,222 | |||||
FI diagnosis | Aspergillosis | 152 | 10.6 | 0.946 | 27.5 (0–368) | 12 | 7895 | <0.0001 | <0.0001 | <0.0001 | |
Candidiasis | 725 | 50.6 | 5068 | 10.3 (0–220) | 5 | 0.690 | |||||
Diaper Candida infection | 74 | 5.2 | 0.469 | 7.7 (0–89) | 0 | 0000 | |||||
Dermatomycosis | 61 | 4.3 | 0.464 | 7.2 (1–46) | 0 | 0000 | |||||
Neonatal Candida infection | 175 | 12.2 | 1407 | 14.0 (1–91) | 1 | 0.571 | |||||
Mycosis from facultative mycosis | 11 | 0.8 | 0.118 | 11.1 (0–53) | 0 | 0000 | |||||
Mycotic otitis | 6 | 0.4 | 0.116 | 8.7 (2–23) | 0 | 0000 | |||||
Pneumonia due to systemic mycosis | 56 | 3.9 | 0.240 | 9.0 (0–65) | 0 | 0000 | |||||
Pneumonia due to Aspergillus | 57 | 4.0 | 0.360 | 35.5 (0–154) | 8 | 14.035 | |||||
Zygomicosis infection | 7 | 0.5 | 0.182 | 25.6 (3–57) | 0 | 0.000 | |||||
Other mycoses | 109 | 7.6 | 0.731 | 29.0 (0–344) | 4 | 3670 | |||||
FI main diagnosis | 241 | 16.8 | 1687 | 13.0 (0–145) | 3 | 1245 | 0.1402 | 0.4458 | 0.09509 | ||
Emergency admission | 931 | 65.0 | 7289 | 12.4 (0–302) | 15 | 1611 | <0.0001 | 0.1227 | <0.0001 | ||
DRG type | Surgical | 77 | 5.4 | 0.530 | 58.0 (0–302) | 10 | 12.987 | <0.0001 | <0.0001 | 0.3884 | |
Medical | 1348 | 94.1 | 10,393 | 12.2 (0–368) | 19 | 1409 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chiusaroli, L.; Cozzolino, C.; Cocchio, S.; Saia, M.; Giaquinto, C.; Donà, D.; Baldo, V. Epidemiological Analysis of Fungal Infection Disease in Pediatric Population: Focus on Hospitalization from 2007 to 2022 in Veneto Region in Italy. Pathogens 2025, 14, 93. https://doi.org/10.3390/pathogens14010093
Chiusaroli L, Cozzolino C, Cocchio S, Saia M, Giaquinto C, Donà D, Baldo V. Epidemiological Analysis of Fungal Infection Disease in Pediatric Population: Focus on Hospitalization from 2007 to 2022 in Veneto Region in Italy. Pathogens. 2025; 14(1):93. https://doi.org/10.3390/pathogens14010093
Chicago/Turabian StyleChiusaroli, Lorenzo, Claudia Cozzolino, Silvia Cocchio, Mario Saia, Carlo Giaquinto, Daniele Donà, and Vincenzo Baldo. 2025. "Epidemiological Analysis of Fungal Infection Disease in Pediatric Population: Focus on Hospitalization from 2007 to 2022 in Veneto Region in Italy" Pathogens 14, no. 1: 93. https://doi.org/10.3390/pathogens14010093
APA StyleChiusaroli, L., Cozzolino, C., Cocchio, S., Saia, M., Giaquinto, C., Donà, D., & Baldo, V. (2025). Epidemiological Analysis of Fungal Infection Disease in Pediatric Population: Focus on Hospitalization from 2007 to 2022 in Veneto Region in Italy. Pathogens, 14(1), 93. https://doi.org/10.3390/pathogens14010093